Common side effects include: Nasopharyngitis and upper respiratory tract infections the most frequently reported adverse effects (mechanism not fully established) Headache and dizziness reported in some patients, particularly during the initial weeks of treatment Gastrointestinal symptoms such as nausea or constipation, though these are generally mild Less common but important safety considerations include: Hypoglycaemia : Although the risk is low when a gliptin is used alone or with metformin, it increases when combined with a sulfonylurea or insulin
PMID: 6 KaplanGG
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial." The Lancet , 402(10404), 529-544
A weak battery causes voltage sag, poor acceleration, and unstable flight performance
doi:10.1034/j.1399-5618.2002.01180.x 16
Recent reports on dermatologic side effects of GLP-1 receptor agonists (GLP-1RAs) have prompted a closer look at how these drugs interact with other treatments, especially isotretinoin, a powerful and highly teratogenic acne medication